Search research articles
Contact Us
Filters
Showing results (251-260 of 434) with videos related to
Page
of 44
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 13, 2009
Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan
Afia Zafar, Rumina Hasan, Shaikh Qamaruddin Nizami, et al.
The Journal of Infectious Diseases
|
January 19, 2005
Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea
Malla R Rao, Thomas F Wierzba, Stephen J Savarino, et al.
Infection and Immunity
|
April 9, 2001
Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine
E R Hall, T F Wierzba, C Ahrén, et al.
Bulletin of the World Health Organization
|
September 25, 2010
Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004
Bai-Qing Dong, Jin Yang, Xuan-Yi Wang, et al.
Tropical Medicine & International Health : TM & IH
|
March 12, 2008
Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique
Lorenz von Seidlein, Xuan-Yi Wang, Arminda Macuamule, et al.
World Journal of Microbiology & Biotechnology
|
July 19, 2012
Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal
Geeta Shakya, Dong Wook Kim, John D Clemens, et al.
American Journal of Clinical Oncology
|
June 11, 1999
Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy
S H Okuno, C O Woodhouse, C L Loprinzi, et al.
Plos One
|
May 8, 2014
Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India
Suman Kanungo, Anna Lena Lopez, Mohammad Ali, et al.
Vaccine
|
October 29, 2013
Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh
Iqbal Ansary Khan, Amit Saha, Fahima Chowdhury, et al.
Plos Neglected Tropical Diseases
|
October 10, 2018
The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis
Ashraful Islam Khan, Ann Levin, Dennis L Chao, et al.
Page
of 44
Search research articles
Search
Showing results (251-260 of 434) with videos related to
Sort By:
Page
of 44
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
January 13, 2009
Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan
Afia Zafar, Rumina Hasan, Shaikh Qamaruddin Nizami, et al.
The Journal of Infectious Diseases
|
January 19, 2005
Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea
Malla R Rao, Thomas F Wierzba, Stephen J Savarino, et al.
Infection and Immunity
|
April 9, 2001
Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine
E R Hall, T F Wierzba, C Ahrén, et al.
Bulletin of the World Health Organization
|
September 25, 2010
Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004
Bai-Qing Dong, Jin Yang, Xuan-Yi Wang, et al.
Tropical Medicine & International Health : TM & IH
|
March 12, 2008
Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique
Lorenz von Seidlein, Xuan-Yi Wang, Arminda Macuamule, et al.
World Journal of Microbiology & Biotechnology
|
July 19, 2012
Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal
Geeta Shakya, Dong Wook Kim, John D Clemens, et al.
American Journal of Clinical Oncology
|
June 11, 1999
Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy
S H Okuno, C O Woodhouse, C L Loprinzi, et al.
Plos One
|
May 8, 2014
Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India
Suman Kanungo, Anna Lena Lopez, Mohammad Ali, et al.
Vaccine
|
October 29, 2013
Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh
Iqbal Ansary Khan, Amit Saha, Fahima Chowdhury, et al.
Plos Neglected Tropical Diseases
|
October 10, 2018
The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis
Ashraful Islam Khan, Ann Levin, Dennis L Chao, et al.
Page
of 44